Recently Updated NPI Information — some details in this NPI profile have been updated in the NPI registry within the last 60 days.

IMOGEN KANE
Prescription History 1003583469
Emergency Medicine in Vancouver, WA

Active since August 24, 2021PECOS Enrolled
12607 SE MILL PLAIN BLVD, VANCOUVER, WA 98684(360) 418-6001 Get Directions

NPPES record last updated: September 2, 2026. Verified against the NPPES registry weekly; last sync: October 25, 2026.

Record update history: Sep 2, 2026, Aug 24, 2021 (2 updates tracked since 2021).

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for IMOGEN KANE, an active Emergency Medicine specialist practicing in Vancouver, WA. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 11 documented patient claims. Among these therapy options, the most frequently utilized medication is Cefpodoxime Proxetil, which accounts for 11 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

1
Medication
11
Total Claims
11
30-Day Fills
Cefpodoxime Proxetil
Most Prescribed · 11 claims
View details
1 medication · 2024 Medicare Part D
Medicare Part D medications prescribed by IMOGEN KANE in 2024, with prescription volumes, average cost per fill, and WA state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other WA PrescribersVs. WA Avg
Cefpodoxime Proxetil11$81.84▼ Less than typical

About Cefpodoxime Proxetil: This medication is used to treat a wide variety of bacterial infections. Show more ▾

This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A prodrug of its active metabolite CEFPODOXIME.

In 2024, this provider wrote 11 Medicare prescriptions for Cefpodoxime Proxetil, about half the volume of the typical Washington prescriber of this medication (19.7). Medicare paid an average of $81.84 per fill, versus $45.70 statewide.

How often this provider prescribes it

This provider
11
WA average
19.7

This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$81.84
WA average
$45.70

Gross Part D cost per fill; not the patient's out-of-pocket price.

11
30-Day Fills
standardized to 30-day supplies
114
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average WA prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the WA average cost per fill.

About this data. The prescription history for IMOGEN KANE is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Emergency Medicine prescribing approach at this Vancouver, WA practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among WA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.